Cargando…

Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers

BACKGROUND: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder without obvious structural abnormalities or consistent associated biomarkers, making its diagnosis difficult. In the present study, we used a urine-based metabolomics approach to identify IBS biomarkers. METHODS: We use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Qihong, Liu, Xinru, Huang, Haojie, Zheng, Xingfeng, Pan, Xue, Fang, Junwei, Meng, Liyuan, Zhou, Chunhua, Zhang, Xiaocui, Li, Zhaoshen, Zou, Duowu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832300/ https://www.ncbi.nlm.nih.gov/pubmed/35154385 http://dx.doi.org/10.1177/1756284819886425

Ejemplares similares

Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
por: Zhou, Chunhua, et al.
Publicado: (2020)

Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome
por: Yu, Lei-Min, et al.
Publicado: (2018)

Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease
por: Zhao, Jiulong, et al.
Publicado: (2019)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Serum biomarkers for irritable bowel syndrome
por: CHIRA, ALEXANDRA, et al.
Publicado: (2015)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Microbial community and metabolomic comparison of irritable bowel syndrome faeces
por: Ponnusamy, Kannan, et al.
Publicado: (2011)

Bottom-up synthesis of ultra-small molybdenum disulfide-polyvinylpyrrolidone nanosheets for imaging-guided tumor regression
por: Zhao, Jiulong, et al.
Publicado: (2017)

Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014)

Aspergillus Metabolome Database for Mass Spectrometry Metabolomics
por: Gil-de-la-Fuente, Alberto, et al.
Publicado: (2021)

Effect of Octreotide on Enteric Motor Neurons in Experimental Acute Necrotizing Pancreatitis
por: Zhou, Hui, et al.
Publicado: (2012)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
por: Plavšić, Ivana, et al.
Publicado: (2015)

Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry
por: Zou, Ying, et al.
Publicado: (2018)

A Case of Neuroendocrine Malignant Tumor with Capsule Retention Diagnosed by Double-Balloon Enteroscopy
por: Chen, Jie, et al.
Publicado: (2010)

Metabolite biomarker discovery for human gastric cancer using dried blood spot mass spectrometry metabolomic approach
por: Wu, Xue, et al.
Publicado: (2022)

Assessing the suitability of capillary electrophoresis‐mass spectrometry for biomarker discovery in plasma‐based metabolomics
por: Zhang, Wei, et al.
Publicado: (2019)

Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry
por: Nizioł, Joanna, et al.
Publicado: (2023)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

Reproducibility of mass spectrometry based metabolomics data
por: Ghosh, Tusharkanti, et al.
Publicado: (2021)

Metabolomics Research in Periodontal Disease by Mass Spectrometry
por: Tsuchida, Sachio, et al.
Publicado: (2022)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
por: Zou, Wei, et al.
Publicado: (2013)

Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder
por: Khan, Zaib Un Nisa, et al.
Publicado: (2022)

Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past
por: Sood, Ruchit, et al.
Publicado: (2015)

Mass Spectrometry and Biomarker Development
por: Rodland, Karin D.
Publicado: (2004)

Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
por: Lin, Xianwei, et al.
Publicado: (2019)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity
por: Han, Lijuan, et al.
Publicado: (2021)

Photothermal transforming agent and chemotherapeutic co-loaded electrospun nanofibers for tumor treatment
por: Zhao, Jiulong, et al.
Publicado: (2019)

Mass spectrometry data of metabolomics analysis of Nepenthes pitchers
por: Rosli, Muhammad Aqil Fitri, et al.
Publicado: (2017)

Machine Learning Applications for Mass Spectrometry-Based Metabolomics
por: Liebal, Ulf W., et al.
Publicado: (2020)

In Silico Optimization of Mass Spectrometry Fragmentation Strategies in Metabolomics
por: Wandy, Joe, et al.
Publicado: (2019)

Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry
por: Zhao, Jingtong, et al.
Publicado: (2021)

Advances in mass spectrometry-based metabolomics for investigation of metabolites
por: Ren, Jun-Ling, et al.
Publicado: (2018)

Qualitative and Quantitative Mass Spectrometry in Salivary Metabolomics and Proteomics
por: Grocholska, Paulina, et al.
Publicado: (2023)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n8jbjv8fme2rfpoa73jlurhjd6